BLCO: bausch.com Price to Earnings Adjusted for Growth Rate

Corporate company logo of Bausch Health (BLCO)

Bausch + Lomb Corporation (BLCO) scalability is based on the automation of lens production and the mass sale of solutions. The PEG investment attractiveness indicator visualizes the business recovery stage, where 0.41 becomes the new value of the metric. Revenues rely on an aging population and regulatory approvals. The result is a stable portfolio of mature products for vision correction and cataract treatment.

BLCO Bausch + Lomb Corporation PEG Multiple (04/28/2023 - 11/16/2026)

Analytical breakdowns for Bausch + Lomb (BLCO)

General company analysis:BLCO Bausch + Lomb Corporation
Core merchandise of bausch.com

For Bausch + Lomb Corporation (BLCO), the implementation of ESG standards and plastic recycling creates a long-term foundation of sustainability that should be reflected in profit dynamics. An analysis of the stock's valuation via the PEG ratio allows for a comparison of the current multiple with the pace of business expansion: a value below one signals that the asset is undervalued relative to its potential, confirming its investment attractiveness.